NY State Assembly Bill 2011-A9781

Assembly Bill A9781

2011-2012 Legislative Session

Establishes a synthetic cannabinoid and substituted cathinone surrender program and relates to controlled substances; repealer

download bill text pdf

Archive: Last Bill Status - In Assembly Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Apr 23, 2012	print number 9781a
Apr 23, 2012	amend and recommit to health
Apr 02, 2012	referred to health

Bill Amendments

Original

A (Active)

2011-A9781 - Details

Current Committee:: Assembly Health
Law Section:: Public Health Law
Laws Affected:: Amd §§3302, 3306 & 3308, rpld §3306 schedule I sub (f) ¶¶ 9 & 10, Pub Health L; amd §§220.00, 220.06, 220.09 & 220.34, Pen L
Versions Introduced in 2013-2014 Legislative Session:: A7893

2011-A9781 - Summary

Establishes a synthetic cannabinoid and substituted cathinone surrender program and relates to controlled substances.

2011-A9781 - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  9781

                          I N  A S S E M B L Y

                              April 2, 2012
                               ___________

Introduced by M. of A. CUSICK -- read once and referred to the Committee
  on Health

AN  ACT  to  establish a synthetic cannabinoid and substituted cathinone
  surrender program; to amend the public health law and the  penal  law,
  in  relation to controlled substances; to repeal certain provisions of
  the public health law, relating to controlled substances; and  provid-
  ing for the repeal of certain provisions upon expiration thereof

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1.  There is hereby established a statewide synthetic cannabi-
noid and substituted  cathinone  surrender  program.  Pursuant  to  this
program, for a period of ninety days commencing on the effective date of
this section:
  The  department of health shall establish a statewide synthetic canna-
binoid and substituted cathinone surrender program, in  compliance  with
federal  law.  The program shall be composed of locations throughout the
state, at which individuals may anonymously surrender products  contain-
ing  synthetic  cannabinoids,  as  defined in section 3302 of the public
health law, and substituted cathinones, as defined in  section  3306  of
the public health law. A surrender of synthetic cannabinoids and substi-
tuted  cathinones pursuant to this section shall not constitute a "sale"
for the purposes of the penal law.
  S 2. Subdivision 4 of section 3302 of the public health law, as  added
by  chapter  878 of the laws of 1972 and as renumbered by chapter 537 of
the laws of 1998, is amended to read as follows:
  4. "Concentrated Cannabis" means
  [(a)] the separated resin, whether crude or purified, obtained from  a
plant of the genus Cannabis[; or
  (b)  a  material,  preparation,  mixture,  compound or other substance
which contains more than two and one-half percent by weight  of  delta-9
tetrahydrocannabinol,  or  its  isomer,  delta-8  dibenzopyran numbering
system, or delta-1 tetrahydrocannabinol or its isomer, delta 1 (6) mono-
terpene numbering system].

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD14796-03-2

A. 9781                             2

  S 3. Subdivisions 33, 34, 35, 36, 37, 38, 39 and 40 of section 3302 of
the public health law are renumbered subdivisions 34, 35,  36,  37,  38,
39, 40 and 41 and a new subdivision 33 is added to read as follows:
  33.  "SYNTHETIC  CANNABINOID" MEANS ANY MATERIAL, COMPOUND, MIXTURE OR
PREPARATION CONTAINING ANY QUANTITY OF:
  (A)  TETRAHYDROCANNABINOLS,  NAPHTHOYLINDOLES,  NAPHTHYLMETHYLINDOLES,
NAPHTHYLIDENEINDENES,  PHENYLACETYLINDOLES, CYCLOHEXYLPHENOLS OR BENZOY-
LINDOLES, AS DEFINED IN SECTION THIRTY-THREE HUNDRED SIX OF THIS TITLE;
  (B) (6AR, 10AR)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)-6A,
7,10,10A-TETRAHYDROBENZO{C}CHROMEN-1-OL (HU-210);
  (C) (6AS, 10AS)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)-
6A,7,10,10A-TETRAHYDROBENZO{C}CHROMEN-1-OL (DEXANABINOL OR HU-211); OR
  (D) 2,3-DIHYDRO-5-METHYL-3-(4-MORPHOLINYLMETHYL)PYRROLO{1,2,3-DE}-1,
4-BENZOXAZIN-6-Y1-1-NAPHTHALENYLMETHANONE (WIN 55,212-2).
  S 4. Subdivision (d) of schedule I  of  section  3306  of  the  public
health  law  is  amended by adding eleven new paragraphs 33, 34, 35, 36,
37, 38, 39, 40, 41, 42 and 43 to read as follows:
  (33) NAPHTHOYLINDOLES. ANY COMPOUND CONTAINING A 3-(1-NAPHTHOYL)INDOLE
STRUCTURE WITH SUBSTITUTION AT THE NITROGEN ATOM OF THE INDOLE  RING  BY
AN   ALKYL,   HALOALKYL,   ALKENYL,  CYCLOALKYLMETHYL,  CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERIDINYL)METHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETH-
ER OR NOT FURTHER SUBSTITUTED IN THE  INDOLE  RING  TO  ANY  EXTENT  AND
WHETHER OR NOT SUBSTITUTED IN THE NAPHTHYL RING TO ANY EXTENT.
  (34)     NAPHTHYLMETHYLINDOLES.     ANY    COMPOUND    CONTAINING    A
3-(1-NAPHTHOYL)INDOLE STRUCTURE WITH SUBSTITUTION AT THE  NITROGEN  ATOM
OF  THE  INDOLE  RING BY AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLMETHYL,
CYCLOALKYLETHYL, 1-(N-METHYL-2-PIPERIDINYL)METHYL  OR  2-(4-MORPHOLINYL)
ETHYL  GROUP,  WHETHER  OR NOT FURTHER SUBSTITUTED IN THE INDOLE RING TO
ANY EXTENT AND WHETHER OR NOT SUBSTITUTED IN THE NAPHTHYL  RING  TO  ANY
EXTENT.
  (35)     NAPHTHYLMETHYLINDOLES.     ANY    COMPOUND    CONTAINING    A
H-INDOL-3-YL-(1-NAPHTHYL)METHANE  STRUCTURE  WITH  SUBSTITUTION  AT  THE
NITROGEN ATOM OF THE INDOLE RING BY AN ALKYL, HALOALKYL, ALKENYL, CYCLO-
ALKYLMETHYL,    CYCLOALKYLETHYL,   1-(N-METHYL-2-PIPERIDINYL)METHYL   OR
2-(4-MORPHOLINYL)ETHYL GROUP, WHETHER OR NOT FURTHER SUBSTITUTED IN  THE
INDOLE RING TO ANY EXTENT AND WHETHER OR NOT SUBSTITUTED IN THE NAPHTHYL
RING TO ANY EXTENT.
  (36)      NAPHTHOYLPYRROLES.     ANY     COMPOUND     CONTAINING     A
3-(1-NAPHTHOYL)PYRROLE STRUCTURE WITH SUBSTITUTION AT THE NITROGEN  ATOM
OF  THE  PYRROLE RING BY AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLMETHYL,
CYCLOALKYLETHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETHER OR NOT  FURTHER
SUBSTITUTED IN THE PYRROLE RING TO ANY EXTENT AND WHETHER OR NOT SUBSTI-
TUTED IN THE NAPHTHYL RING TO ANY EXTENT.
  (37)  NAPHTHYLIDENEINDENES. ANY COMPOUND CONTAINING A NAPHTHYLIDENEIN-
DENE STRUCTURE WITH SUBSTITUTION AT THE 3-POSITION OF THE INDENE RING BY
AN  ALKYL,  HALOALKYL,   ALKENYL,   CYCLOALKYLMETHYL,   CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERIDINYL)METHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETH-
ER  OR  NOT  FURTHER  SUBSTITUTED  IN  THE INDENE RING TO ANY EXTENT AND
WHETHER OR NOT SUBSTITUTED IN THE NAPHTHYL RING TO ANY EXTENT.
  (38) PHENYLACETYLINDOLES. ANY COMPOUND CONTAINING A  3-PHENYLACETYLIN-
DOLE STRUCTURE WITH SUBSTITUTION AT THE NITROGEN ATOM OF THE INDOLE RING
BY  AN  ALKYL,  HALOALKYL,  ALKENYL,  CYCLOALKYLMETHYL, CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERIDINYL)METHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETH-
ER OR NOT FURTHER SUBSTITUTED IN THE  INDOLE  RING  TO  ANY  EXTENT  AND
WHETHER OR NOT SUBSTITUTED IN THE PHENYL RING TO ANY EXTENT.

A. 9781                             3

  (39)      CYCLOHEXYLPHENOLS.     ANY     COMPOUND     CONTAINING     A
2-(3-HYDROXYCYCLOHEXYL)PHENOL STRUCTURE WITH SUBSTITUTION AT THE 5-POSI-
TION OF THE PHENOLIC RING BY AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLME-
THYL,     CYCLOALKYLETHYL,      1-(N-METHYL-2-PIPERIDINYL)METHYL      OR
2-(4-MORPHOLINYL)ETHYL  GROUP,  WHETHER OR NOT SUBSTITUTED IN THE CYCLO-
HEXYL RING TO ANY EXTENT.
  (40)  BENZOYLINDOLES.  ANY  COMPOUND  CONTAINING  A  3-(BENZOYL)INDOLE
STRUCTURE  WITH  SUBSTITUTION AT THE NITROGEN ATOM OF THE INDOLE RING BY
AN  ALKYL,  HALOALKYL,   ALKENYL,   CYCLOALKYLMETHYL,   CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERIDINYL)METHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETH-
ER  OR  NOT  FURTHER  SUBSTITUTED  IN  THE INDOLE RING TO ANY EXTENT AND
WHETHER OR NOT SUBSTITUTED IN THE PHENYL RING TO ANY EXTENT.
  (41)  (6AR,10AR)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)
-6A,7,10,10A-TETRAHYDROBENZO{C}CHROMEN-1-OL (HU-210).
  (42)  (6AS,10AS)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)
-6A,7,10,10A-TETRAHYDROBENZO{C}CHROMEN-1-OL (DEXANABINOL OR HU-211).
  (43)  2,3-DIHYDRO-5-METHYL-3-(4-MORPHOLINYLMETHYL)PYRROLO{1,2,3-DE}-1,
4-BENZOXAZIN-6-YL-1-NAPHTHALENYLMETHANONE (WIN 55,212-2).
  S  5.  Paragraph 5 of subdivision (f) of schedule I of section 3306 of
the public health law, as amended by chapter 457 of the laws of 2006, is
amended to read as follows:
  (5) [Methcathinone (some other names: 2-(methylamino) - propiophenone;
alpha-(methylamino)   propiophenone;    2-(methylamino) -1-phenylpropan-
1-one;  alpha-N-methylaminopropiophenone;  monomethylpropion; ephedrone,
N-methylcathinone, methylcathinone; AL-464; AL-422; AL-463 and  UR1432),
its  salts,  optical  isomers  and salts of optical isomers] SUBSTITUTED
CATHINONES. ANY COMPOUND, OTHER THAN BUPROPRION,  THAT  IS  STRUCTURALLY
DERIVED  FROM 2-AMINO-1-PHENYL-1-PROPANONE BY MODIFICATION IN ANY OF THE
FOLLOWING WAYS:
  (I) BY SUBSTITUTION IN THE PHENYL  RING  TO  ANY  EXTENT  WITH  ALKYL,
ALKOXY, ALKYLENEDIOXY, HALOALKYL, OR HALIDE SUBSTITUENTS, WHETHER OR NOT
FURTHER  SUBSTITUTED  IN  THE PHENYL RING BY ONE OR MORE OTHER UNIVALENT
SUBSTITUENTS;
  (II) BY SUBSTITUTION AT THE 3-POSITION WITH AN ALKYL SUBSTITUTENT;
  (III) BY SUBSTITUTION AT THE  NITROGEN  ATOM  WITH  ALKYL  OR  DIALKYL
GROUPS, OR BY INCLUSION OF THE NITROGEN ATOM IN A CYCLIC STRUCTURE.
  S  6.  Paragraphs 9 and 10 of subdivision (f) of schedule I of section
3306 of the public health law are REPEALED.
  S 7. Section 3308 of the public health law is amended by adding a  new
subdivision 7 to read as follows:
  7.  THE COMMISSIONER SHALL, IN CONJUNCTION WITH THE DIVISION OF CRIMI-
NAL JUSTICE  SERVICES,  ESTABLISH  AND  MAINTAIN  A  DATABASE  OF  KNOWN
SYNTHETIC  CANNABINOIDS,  AS DEFINED IN SECTION THIRTY-THREE HUNDRED TWO
OF THIS TITLE, AND SUBSTITUTED CATHINONES, AS DEFINED IN  SECTION  THIR-
TY-THREE  HUNDRED  SIX OF THIS TITLE. THE DATABASE SHALL BE PUBLISHED ON
THE DEPARTMENT'S WEBSITE SO THAT CONSUMERS, RETAILERS, AND LAW  ENFORCE-
MENT AGENCIES CAN ACCESS INFORMATION INCLUDING, BUT NOT LIMITED TO:
  (A)  A  LIST  OF COMPOUNDS KNOWN TO BELONG TO THE CLASSES OF CHEMICALS
LISTED ABOVE, AND THEIR TRADE NAMES;
  (B)  A  PHYSICAL  DESCRIPTION  OF  PRODUCTS  KNOWN  TO  CONTAIN   SUCH
COMPOUNDS, AND THEIR EFFECTS; AND
  (C)  A  LIST  OF  THE  BRAND  NAMES  OF PRODUCTS KNOWN TO CONTAIN SUCH
COMPOUNDS, AND IMAGES OF THEIR PACKAGING.
  THE WEBSITE SHALL INCLUDE A STATEMENT INDICATING THAT SUCH INFORMATION
IS BEING PROVIDED AS  A  RESOURCE  FOR  CONSUMERS,  RETAILERS,  AND  LAW
ENFORCEMENT;  AND,  DUE  TO  THE  NATURE OF THE ILLEGAL DRUG TRADE, SUCH

A. 9781                             4

INFORMATION MAY NOT BE COMPREHENSIVE. NEITHER  THE  DEPARTMENT  NOR  THE
DIVISION  OF  CRIMINAL JUSTICE SERVICES SHALL BE LIABLE FOR ANY ECONOMIC
HARM, PERSONAL  INJURY,  OR  DEATH  THAT  MAY  RESULT  FROM  INFORMATION
INCLUDED IN, OR OMITTED FROM, THE DATABASE.
  S  8.  Subdivisions  5,  6  and 10 of section 220.00 of the penal law,
subdivision 5 as amended by chapter 537 of the laws of 1998, subdivision
6 as amended by chapter 1051 of the laws of 1973 and subdivision  10  as
amended  by  chapter  664  of  the  laws of 1985, are amended to read as
follows:
  5. "Controlled substance" means any substance listed  in  schedule  I,
II,  III,  IV  or  V  of  section thirty-three hundred six of the public
health law other than marihuana, but including concentrated cannabis  as
defined  in  [paragraph (a) of] subdivision four of section thirty-three
hundred two of such law.
  6. "Marihuana" means "marihuana[" or],"  "concentrated  cannabis,"  OR
"SYNTHETIC  CANNABINOID"  as  those terms are defined in section thirty-
three hundred two of the public health law.
  10. "Hallucinogenic substance" means any controlled  substance  listed
in  schedule  I(d)  other than concentrated cannabis, SYNTHETIC CANNABI-
NOIDS, lysergic acid diethylamide, or an hallucinogen.
  S 9. Subdivision 4 of section 220.06 of the penal law, as  amended  by
chapter 537 of the laws of 1998, is amended to read as follows:
  4.  one  or  more  preparations,  compounds,  mixtures  or  substances
containing concentrated cannabis as defined in [paragraph (a) of] subdi-
vision four of section thirty-three hundred two of the public health law
and said preparations, compounds,  mixtures  or  substances  are  of  an
aggregate weight of one-fourth ounce or more; or
  S 10. Subdivision 10 of section 220.09 of the penal law, as amended by
chapter 537 of the laws of 1998, is amended to read as follows:
  10.  one  or  more  preparations,  compounds,  mixtures  or substances
containing concentrated cannabis as defined in [paragraph (a) of] subdi-
vision four of section thirty-three hundred two of the public health law
and said preparations, compounds,  mixtures  or  substances  are  of  an
aggregate weight of one ounce or more; or
  S  11. Subdivision 3 of section 220.34 of the penal law, as amended by
chapter 537 of the laws of 1998, is amended to read as follows:
  3. concentrated cannabis as defined in [paragraph (a) of]  subdivision
four of section thirty-three hundred two of the public health law; or
  S  12.  This act shall take effect on the ninetieth day after it shall
have become a law; provided, however, that the  commissioner  of  health
and the division of criminal justice services shall immediately take the
actions  necessary  to ensure that the database created by subdivision 7
of section 3308 of the public health law, as added by section  seven  of
this  act,  and the surrender program established by section one of this
act, shall become operational  on  such  effective  date;  and  provided
further,  that, notwithstanding the provisions of any law to the contra-
ry, for ninety days after  this  act  shall  have  become  law,  section
220.03,  220.06, 220.09, 220.16, 220.18, 220.21, 221.10, 221.15, 221.20,
221.25 or 221.30 of the penal law shall not be enforced with  regard  to
the  possession of synthetic cannabinoids, as defined in section 3302 of
the public health law, or substituted cathinones, as defined in  section
3306  of  the  public  health  law,  except  that  enforcement  of  such
provisions of penal law shall be allowed during this period with  regard
to the possession of methacathinone, 4-methylmethcathinone, methylenedi-
oxypyrovalerone,  and  substances  containing more than two and one-half
percent by  weight  of  delta-9  tetrahydrocannabinol,  or  its  isomer,

A. 9781                             5

delta-8  dibenzopyran  numbering system, or delta-1 tetrahydrocannabinol
or its isomer, delta 1(6) monoterpene numbering  system;  and  provided,
further, that the provisions of section one of this act shall expire and
be deemed repealed on the ninety-first day after such effective date.

co-Sponsors

multi-Sponsors

2011-A9781A (ACTIVE) - Details

Current Committee:: Assembly Health
Law Section:: Public Health Law
Laws Affected:: Amd §§3302, 3306 & 3308, rpld §3306 schedule I sub (f) ¶¶ 9 & 10, Pub Health L; amd §§220.00, 220.06, 220.09 & 220.34, Pen L
Versions Introduced in 2013-2014 Legislative Session:: A7893

2011-A9781A (ACTIVE) - Summary

Establishes a synthetic cannabinoid and substituted cathinone surrender program and relates to controlled substances.

2011-A9781A (ACTIVE) - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 9781--A

                          I N  A S S E M B L Y

                              April 2, 2012
                               ___________

Introduced by M. of A. CUSICK -- read once and referred to the Committee
  on  Health -- committee discharged, bill amended, ordered reprinted as
  amended and recommitted to said committee

AN ACT to establish a synthetic cannabinoid  and  substituted  cathinone
  surrender  program;  to amend the public health law and the penal law,
  in relation to controlled substances; to repeal certain provisions  of
  the  public health law, relating to controlled substances; and provid-
  ing for the repeal of certain provisions upon expiration thereof

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1.  There is hereby established a statewide synthetic cannabi-
noid  and  substituted  cathinone  surrender  program.  Pursuant to this
program, for a period of ninety days commencing on the effective date of
this section:
  The department of health shall establish a statewide synthetic  canna-
binoid  and  substituted cathinone surrender program, in compliance with
federal law. The program shall be composed of locations  throughout  the
state,  at which individuals may anonymously surrender products contain-
ing synthetic cannabinoids, as defined in section  3302  of  the  public
health  law,  and  substituted cathinones, as defined in section 3306 of
the public health law. A surrender of synthetic cannabinoids and substi-
tuted cathinones pursuant to this section shall not constitute a  "sale"
for the purposes of the penal law.
  S  2. Subdivision 4 of section 3302 of the public health law, as added
by chapter 878 of the laws of 1972 and as renumbered by chapter  537  of
the laws of 1998, is amended to read as follows:
  4. "Concentrated Cannabis" means
  [(a)]  the separated resin, whether crude or purified, obtained from a
plant of the genus Cannabis[; or
  (b) a material, preparation,  mixture,  compound  or  other  substance
which  contains  more than two and one-half percent by weight of delta-9
tetrahydrocannabinol, or  its  isomer,  delta-8  dibenzopyran  numbering
system, or delta-1 tetrahydrocannabinol or its isomer, delta 1 (6) mono-
terpene numbering system].

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.

                                                           LBD14796-05-2

A. 9781--A                          2

  S 3. Subdivisions 33, 34, 35, 36, 37, 38, 39 and 40 of section 3302 of
the  public  health  law are renumbered subdivisions 34, 35, 36, 37, 38,
39, 40 and 41 and a new subdivision 33 is added to read as follows:
  33.  "SYNTHETIC  CANNABINOID" MEANS ANY MATERIAL, COMPOUND, MIXTURE OR
PREPARATION CONTAINING ANY QUANTITY OF:
  (A)  TETRAHYDROCANNABINOLS,  NAPHTHOYLINDOLES,  NAPHTHYLMETHYLINDOLES,
NAPHTHOYLPYRROLES,  NAPHTHYLIDENEINDENES, PHENYLACETYLINDOLES, CYCLOHEX-
YLPHENOLS, BENZOYLINDOLES, OR ADAMANTOYLINDOLES, AS DEFINED  IN  SECTION
THIRTY-THREE HUNDRED SIX OF THIS TITLE;
  (B) (6AR, 10AR)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)-
6A,7,10,10A-TETRAHYDROBENZO{C}CHROMEN-1-OL (HU-210);
  (C) (6AS, 10AS)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)-
6A,7,10,10A-TETRAHYDROBENZO{C}CHROMEN-1-OL (DEXANABINOL OR HU-211); OR
  (D) 2,3-DIHYDRO-5-METHYL-3-(4-MORPHOLINYLMETHYL)PYRROLO{1,2,3-DE}-1,
4-BENZOXAZIN-6-Y1-1-NAPHTHALENYLMETHANONE (WIN 55,212-2).
  S  4.  Subdivision  (d)  of  schedule  I of section 3306 of the public
health law is amended by adding eleven new paragraphs 33,  34,  35,  36,
37, 38, 39, 40, 41, 42 and 43 to read as follows:
  (33) NAPHTHOYLINDOLES. ANY COMPOUND CONTAINING A 3-(1-NAPHTHOYL)INDOLE
STRUCTURE  WITH  SUBSTITUTION AT THE NITROGEN ATOM OF THE INDOLE RING BY
AN  ALKYL,  HALOALKYL,   ALKENYL,   CYCLOALKYLMETHYL,   CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERIDINYL)METHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETH-
ER  OR  NOT  FURTHER  SUBSTITUTED  IN  THE INDOLE RING TO ANY EXTENT AND
WHETHER OR NOT SUBSTITUTED IN THE NAPHTHYL RING TO ANY EXTENT.
  (34)    NAPHTHYLMETHYLINDOLES.    ANY    COMPOUND     CONTAINING     A
H-INDOL-3-YL-(1-NAPHTHYL)METHANE  STRUCTURE  WITH  SUBSTITUTION  AT  THE
NITROGEN ATOM OF THE INDOLE RING BY AN ALKYL, HALOALKYL, ALKENYL, CYCLO-
ALKYLMETHYL,   CYCLOALKYLETHYL,   1-(N-METHYL-2-PIPERIDINYL)METHYL    OR
2-(4-MORPHOLINYL)ETHYL  GROUP, WHETHER OR NOT FURTHER SUBSTITUTED IN THE
INDOLE RING TO ANY EXTENT AND WHETHER OR NOT SUBSTITUTED IN THE NAPHTHYL
RING TO ANY EXTENT.
  (35)     NAPHTHOYLPYRROLES.     ANY     COMPOUND     CONTAINING      A
3-(1-NAPHTHOYL)PYRROLE  STRUCTURE WITH SUBSTITUTION AT THE NITROGEN ATOM
OF THE PYRROLE RING BY AN ALKYL, HALOALKYL,  ALKENYL,  CYCLOALKYLMETHYL,
CYCLOALKYLETHYL  OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETHER OR NOT FURTHER
SUBSTITUTED IN THE PYRROLE RING TO ANY EXTENT AND WHETHER OR NOT SUBSTI-
TUTED IN THE NAPHTHYL RING TO ANY EXTENT.
  (36) NAPHTHYLIDENEINDENES. ANY COMPOUND CONTAINING A  NAPHTHYLIDENEIN-
DENE STRUCTURE WITH SUBSTITUTION AT THE 3-POSITION OF THE INDENE RING BY
AN   ALKYL,   HALOALKYL,   ALKENYL,  CYCLOALKYLMETHYL,  CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERIDINYL)METHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETH-
ER OR NOT FURTHER SUBSTITUTED IN THE  INDENE  RING  TO  ANY  EXTENT  AND
WHETHER OR NOT SUBSTITUTED IN THE NAPHTHYL RING TO ANY EXTENT.
  (37)  PHENYLACETYLINDOLES. ANY COMPOUND CONTAINING A 3-PHENYLACETYLIN-
DOLE STRUCTURE WITH SUBSTITUTION AT THE NITROGEN ATOM OF THE INDOLE RING
BY AN  ALKYL,  HALOALKYL,  ALKENYL,  CYCLOALKYLMETHYL,  CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERIDINYL)METHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETH-
ER  OR  NOT  FURTHER  SUBSTITUTED  IN  THE INDOLE RING TO ANY EXTENT AND
WHETHER OR NOT SUBSTITUTED IN THE PHENYL RING TO ANY EXTENT.
  (38)     CYCLOHEXYLPHENOLS.     ANY     COMPOUND     CONTAINING      A
2-(3-HYDROXYCYCLOHEXYL)PHENOL STRUCTURE WITH SUBSTITUTION AT THE 5-POSI-
TION OF THE PHENOLIC RING BY AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLME-
THYL,      CYCLOALKYLETHYL,      1-(N-METHYL-2-PIPERIDINYL)METHYL     OR
2-(4-MORPHOLINYL)ETHYL GROUP, WHETHER OR NOT SUBSTITUTED IN  THE  CYCLO-
HEXYL RING TO ANY EXTENT.

A. 9781--A                          3

  (39)  BENZOYLINDOLES.  ANY  COMPOUND  CONTAINING  A  3-(BENZOYL)INDOLE
STRUCTURE WITH SUBSTITUTION AT THE NITROGEN ATOM OF THE INDOLE  RING  BY
AN   ALKYL,   HALOALKYL,   ALKENYL,  CYCLOALKYLMETHYL,  CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERIDINYL)METHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETH-
ER  OR  NOT  FURTHER  SUBSTITUTED  IN  THE INDOLE RING TO ANY EXTENT AND
WHETHER OR NOT SUBSTITUTED IN THE PHENYL RING TO ANY EXTENT.
  (40) ADAMANTOYLINDOLES. ANY  COMPOUND  CONTAINING  A  3-(1-ADAMANTOYL)
INDOLE  STRUCTURE  WITH  SUBSTITUTION AT THE NITROGEN ATOM OF THE INDOLE
RING BY AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLMETHYL, CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERINDINYL)METHYL,  OR   2-(4-MORPHOLINYL)ETHYL   GROUP,
WHETHER  OR  NOT FURTHER SUBSTITUTED IN THE ADAMANTYL RING SYSTEM TO ANY
EXTENT.
  (41)  (6AR,10AR)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)
-6A,7,10,10A-TETRAHYDROBENZO{C}CHROMEN-1-OL (HU-210).
  (42)  (6AS,10AS)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)
-6A,7,10,10A-TETRAHYDROBENZO{C}CHROMEN-1-OL (DEXANABINOL OR HU-211).
  (43)  2,3-DIHYDRO-5-METHYL-3-(4-MORPHOLINYLMETHYL)PYRROLO{1,2,3-DE}-1,
4-BENZOXAZIN-6-YL-1-NAPHTHALENYLMETHANONE (WIN 55,212-2).
  S  5.  Paragraph 5 of subdivision (f) of schedule I of section 3306 of
the public health law, as amended by chapter 457 of the laws of 2006, is
amended to read as follows:
  (5) [Methcathinone (some other names: 2-(methylamino) - propiophenone;
alpha-(methylamino)   propiophenone;    2-(methylamino) -1-phenylpropan-
1-one;  alpha-N-methylaminopropiophenone;  monomethylpropion; ephedrone,
N-methylcathinone, methylcathinone; AL-464; AL-422; AL-463 and  UR1432),
its  salts,  optical  isomers  and salts of optical isomers] SUBSTITUTED
CATHINONES. ANY COMPOUND, OTHER THAN BUPROPRION,  THAT  IS  STRUCTURALLY
DERIVED  FROM 2-AMINO-1-PHENYL-1-PROPANONE BY MODIFICATION IN ANY OF THE
FOLLOWING WAYS:
  (I) BY SUBSTITUTION IN THE PHENYL  RING  TO  ANY  EXTENT  WITH  ALKYL,
ALKOXY, ALKYLENEDIOXY, HALOALKYL, OR HALIDE SUBSTITUENTS, WHETHER OR NOT
FURTHER  SUBSTITUTED  IN  THE PHENYL RING BY ONE OR MORE OTHER UNIVALENT
SUBSTITUENTS;
  (II) BY SUBSTITUTION AT THE 3-POSITION WITH AN ALKYL SUBSTITUTENT;
  (III) BY SUBSTITUTION AT THE  NITROGEN  ATOM  WITH  ALKYL  OR  DIALKYL
GROUPS, OR BY INCLUSION OF THE NITROGEN ATOM IN A CYCLIC STRUCTURE.
  S  6.  Paragraphs 9 and 10 of subdivision (f) of schedule I of section
3306 of the public health law are REPEALED.
  S 7. Section 3308 of the public health law is amended by adding a  new
subdivision 7 to read as follows:
  7.  THE COMMISSIONER SHALL, IN CONJUNCTION WITH THE DIVISION OF CRIMI-
NAL JUSTICE  SERVICES,  ESTABLISH  AND  MAINTAIN  A  DATABASE  OF  KNOWN
SYNTHETIC  CANNABINOIDS,  AS DEFINED IN SECTION THIRTY-THREE HUNDRED TWO
OF THIS TITLE, AND SUBSTITUTED CATHINONES, AS DEFINED IN  SECTION  THIR-
TY-THREE  HUNDRED  SIX OF THIS TITLE. THE DATABASE SHALL BE PUBLISHED ON
THE DEPARTMENT'S WEBSITE SO THAT CONSUMERS, RETAILERS, AND LAW  ENFORCE-
MENT AGENCIES CAN ACCESS INFORMATION INCLUDING, BUT NOT LIMITED TO:
  (A)  A  LIST  OF COMPOUNDS KNOWN TO BELONG TO THE CLASSES OF CHEMICALS
LISTED ABOVE, AND THEIR TRADE NAMES;
  (B)  A  PHYSICAL  DESCRIPTION  OF  PRODUCTS  KNOWN  TO  CONTAIN   SUCH
COMPOUNDS, AND THEIR EFFECTS; AND
  (C)  A  LIST  OF  THE  BRAND  NAMES  OF PRODUCTS KNOWN TO CONTAIN SUCH
COMPOUNDS, AND IMAGES OF THEIR PACKAGING.
  THE WEBSITE SHALL INCLUDE A STATEMENT INDICATING THAT SUCH INFORMATION
IS BEING PROVIDED AS  A  RESOURCE  FOR  CONSUMERS,  RETAILERS,  AND  LAW
ENFORCEMENT;  AND,  DUE  TO  THE  NATURE OF THE ILLEGAL DRUG TRADE, SUCH

A. 9781--A                          4

INFORMATION MAY NOT BE COMPREHENSIVE. NEITHER  THE  DEPARTMENT  NOR  THE
DIVISION  OF  CRIMINAL JUSTICE SERVICES SHALL BE LIABLE FOR ANY ECONOMIC
HARM, PERSONAL  INJURY,  OR  DEATH  THAT  MAY  RESULT  FROM  INFORMATION
INCLUDED IN, OR OMITTED FROM, THE DATABASE.
  S  8.  Subdivisions  5,  6  and 10 of section 220.00 of the penal law,
subdivision 5 as amended by chapter 537 of the laws of 1998, subdivision
6 as amended by chapter 1051 of the laws of 1973 and subdivision  10  as
amended  by  chapter  664  of  the  laws of 1985, are amended to read as
follows:
  5. "Controlled substance" means any substance listed  in  schedule  I,
II,  III,  IV  or  V  of  section thirty-three hundred six of the public
health law other than marihuana, but including concentrated cannabis  as
defined  in  [paragraph (a) of] subdivision four, AND SYNTHETIC CANNABI-
NOID AS DEFINED IN SUBDIVISION  THIRTY-THREE,  of  section  thirty-three
hundred two of such law.
  6.  "Marihuana"  means  "marihuana[" or]," "concentrated cannabis," OR
"SYNTHETIC CANNABINOID" as those terms are defined  in  section  thirty-
three hundred two of the public health law.
  10.  "Hallucinogenic  substance" means any controlled substance listed
in schedule I(d) other than concentrated  cannabis,  SYNTHETIC  CANNABI-
NOIDS, lysergic acid diethylamide, or an hallucinogen.
  S  9.  Subdivision 4 of section 220.06 of the penal law, as amended by
chapter 537 of the laws of 1998, is amended to read as follows:
  4.  one  or  more  preparations,  compounds,  mixtures  or  substances
containing concentrated cannabis as defined in [paragraph (a) of] subdi-
vision  four  of  section  thirty-three hundred two of the public health
law, OR SYNTHETIC CANNABINOID AS DEFINED IN SUBDIVISION THIRTY-THREE  OF
SECTION  THIRTY-THREE  HUNDRED  TWO  OF  THE PUBLIC HEALTH LAW, and said
preparations, compounds, mixtures or  substances  are  of  an  aggregate
weight of one-fourth ounce or more; or
  S 10. Subdivision 10 of section 220.09 of the penal law, as amended by
chapter 537 of the laws of 1998, is amended to read as follows:
  10.  one  or  more  preparations,  compounds,  mixtures  or substances
containing concentrated cannabis as defined in [paragraph (a) of] subdi-
vision four of section thirty-three hundred two  of  the  public  health
law,  OR SYNTHETIC CANNABINOID AS DEFINED IN SUBDIVISION THIRTY-THREE OF
SECTION THIRTY-THREE HUNDRED TWO OF THE  PUBLIC  HEALTH  LAW,  and  said
preparations,  compounds,  mixtures  or  substances  are of an aggregate
weight of one ounce or more; or
  S 11. Subdivision 3 of section 220.34 of the penal law, as amended  by
chapter 537 of the laws of 1998, is amended to read as follows:
  3.  concentrated cannabis as defined in [paragraph (a) of] subdivision
four of section thirty-three hundred two of the public  health  law,  OR
SYNTHETIC  CANNABINOID AS DEFINED IN SUBDIVISION THIRTY-THREE OF SECTION
THIRTY-THREE HUNDRED TWO OF THE PUBLIC HEALTH LAW; or
  S 12. This act shall take effect on the ninetieth day after  it  shall
have  become  a  law; provided, however, that the commissioner of health
and the division of criminal justice services shall immediately take the
actions necessary to ensure that the database created by  subdivision  7
of  section  3308 of the public health law, as added by section seven of
this act, and the surrender program established by section one  of  this
act,  shall  become  operational  on  or before such effective date; and
provided further, that, notwithstanding the provisions of any law to the
contrary, for ninety days after this act shall have become law,  section
220.03,  220.06, 220.09, 220.16, 220.18, 220.21, 221.05, 221.10, 221.15,
221.20, 221.25 or 221.30 of the penal law shall  not  be  enforced  with

A. 9781--A                          5

regard  to  the  possession  of  synthetic  cannabinoids,  as defined in
section 3302 of the public health law,  or  substituted  cathinones,  as
defined  in  section 3306 of the public health law, except that enforce-
ment  of  such  provisions of the penal law shall be allowed during this
period with regard to the possession  of  methacathinone,  4-methylmeth-
cathinone,  methylenedioxypyrovalerone,  and  substances containing more
than two and one-half percent by weight of delta-9 tetrahydrocannabinol,
or its isomer, delta-8 dibenzopyran numbering system, or delta-1 tetrah-
ydrocannabinol or its isomer, delta 1(6) monoterpene  numbering  system;
and  provided,  further,  that the provisions of section one of this act
shall expire and be deemed repealed on the ninety-first day  after  such
effective date.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Assembly Bill A9781

Share this bill

Sponsored By

CUSICK